Regulatory Spine Top Stories VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression byJosh SandbergSeptember 29, 2026
Recon Regulatory Sports Medicine Top Stories Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation byTim AllenJuly 30, 2026
Regulatory Spine Top Stories SpinaFX Medical receives FDA Investigational Device Exemption (IDE) for Triojection®, its Breakthrough, Minimally-Invasive, Image-Guided Lumbar Disc Treatment. byJosh SandbergJune 9, 2026
Recon Regulatory Top Stories Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant byJosh SandbergApril 30, 2026
Spine Top Stories Synergy Spine Solutions® Receives FDA Approval for its Synergy Disc®, Expanding Cervical Disc Replacement Options for U.S. Patients byNoah SimmonsFebruary 27, 2026
Regulatory Spine Top Stories FDA Grants PMA Approval to LimiFlex™ Dynamic Sagittal Tether byTim AllenFebruary 18, 2026
Regulatory Sports Medicine Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain byTim AllenDecember 15, 2025
Regulatory Spine Top Stories Companion Spine Announces FDA Premarket Approval (“PMA”) of the DIAM™ Spinal Stabilization System for the Treatment of Degenerative Disc Disease (“DDD”) byJosh SandbergDecember 15, 2025
Extremities Regulatory Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin byTim AllenDecember 15, 2025
Biologics Regulatory Spine BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergNovember 17, 2025
